Eraxis Anidulafungin Injection 100 mg/vl Powder SDV 10 mg (RX)

Eraxis Injection 100mg/vl Powder SDV 10mg – [Anidulafungin] Prescription Antifungal Medication

Eraxis Injection 100mg/vial (Powder SDV 10mg) is a leading antifungal medication containing Anidulafungin – clinically proven for the treatment of serious, systemic fungal infections. Used inpatient and in hospital settings, Eraxis targets life-threatening candidemia, esophageal candidiasis, and other invasive Candida infections in adults. This FDA-approved echinocandin class antifungal works by inhibiting the formation of fungal cell walls, eliminating fungi at the source without compromising human cells.

Key Features and Benefits

• 100mg Anidulafungin per Vial – Ensures potent, rapid antifungal action
• Sterile Powder for Solution – Reconstitute for safe, precise intravenous administration
• Broad-Spectrum Antifungal Coverage – Effective against Candida albicans, C. glabrata, C. tropicalis, C. krusei, and more
• Powerful for Systemic Fungal Infections – Indicated for candidemia, intra-abdominal abscesses, peritonitis, esophageal candidiasis
• FDA Approved & Hospital Grade – Proven safety and efficacy in rigorous clinical trials
• Minimal Drug Interactions – Lower risk compared to azole antifungals; no CYP450 inhibition
• Once-Daily Dosing – Convenient, consistent therapeutic levels

Indications & Usage

Eraxis (Anidulafungin) 100mg/vl is indicated for:

• Candidemia (Bloodstream Fungal Infections)
• Invasive Candidiasis (including intra-abdominal abscess, peritonitis)
• Esophageal Candidiasis
• Fungal Infection Prophylaxis in Immunocompromised Patients (including neutropenic and chemotherapy patients)
• Resistant Fungal Infections where first-line antifungals fail

How Eraxis Injection Works

Eraxis Injection features a unique mechanism of action by inhibiting 1,3-β-D-glucan synthase, a key enzyme in fungal cell wall synthesis. This weakens and destroys fungal cells, offering fungicidal effects against pathogenic yeast species, including those resistant to fluconazole and other azoles.

Top Health Benefits

• Fast, Potent Infection Eradication: Rapidly reduces systemic fungal load, enhancing survival rates in at-risk hospital patients
• Critical for ICU, Neutropenic, and Immunocompromised Patients: Protects vulnerable populations from severe fungal infections
• Low Risk of Hepatotoxicity & Renal Impairment: Safer alternative for patients with liver or kidney dysfunction
• Decreased Mortality in Sepsis & Bloodstream Infections: When used as part of early, targeted therapy protocols

Directions for Use

1. Reconstitute sterile powder with provided solvent following approved medical guidelines.
2. Administer intravenously as an infusion over recommended time under supervision of a healthcare professional.
3. Typical Dose: 100mg loading dose, followed by 50mg daily for desired treatment duration (as per medical prescription).

Safety Information & Side Effects

• Possible Side Effects: Infusion reactions, nausea, headache, hypokalemia, elevated liver enzymes.
• Contraindications: Known allergy to Anidulafungin or excipients.
• Pregnancy & Lactation: Use only as prescribed; consult with a physician.

Frequently Asked Questions

Q: What is Eraxis Injection used for?

A: Eraxis Injection is a hospital-grade antifungal for severe fungal infections like candidemia, invasive candidiasis, and esophageal candidiasis.

Q: Is Eraxis safe for patients with liver disease or renal impairment?

A: Yes! Eraxis (Anidulafungin) is non-hepatotoxic and rarely requires dose adjustment for liver or kidney impairment.

Q: How is Eraxis Injection administered?

A: It is administered intravenously by healthcare professionals, ensuring precise and effective delivery.

Order Eraxis Injection 100mg/vl Powder SDV 10mg Today!

Experience precision antifungal therapy and superior protection against dangerous systemic fungal infections with Eraxis. For hospital, clinics, and physician use – ERA-Grade Anidulafungin for optimized patient outcomes.